Energy and Protein Adequacy of Oral Intake After Ventilator Withdrawal Among Critically Ill Patients.
NCT ID: NCT05548400
Last Updated: 2022-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2022-03-01
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Intake in Patients on Noninvasive Ventilation: a Prospective Observational Study
NCT06740981
Non-inferiority of a Strategy of Continuing Oral Intake Compared With Fasting
NCT06510972
Prevention of Refeeding Syndrome
NCT06589479
Impact of Early Parenteral Nutrition Completing Enteral Nutrition in Adult Critically Ill Patients
NCT00512122
Pilot: Feasibility of Intermittent Enteral Feeding in Ventilated MICU Patients
NCT04164108
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
To characterize the study population, general characteristics of patients and their hospital outcomes will be collected: sociodemographic (age, sex, ethnicity, education) and admission clinical data (weight, height, Simplified Acute Physiology Score 3, Nutritional Risk Screening, and Subjective Global Assessment), energy and protein intake within 72 hours after initiation of invasive mechanical ventilation, the underlying disease that led to hospitalization, length of stay in the ICU, length of invasive mechanical ventilation and hospital stay, the incidence of infections after ICU discharge and in-hospital death.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Criticaly ill patients who remained on invasive mechanical ventilation for at least 48 hours.
Criticaly ill patients who remained on invasive mechanical ventilation for at least 48 hours, and dietary followed up after ventilator withdrawal.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mechanical ventilation for at least 48 hours and who migrate to exclusively oral feeding within seven days after extubation without receiving complementary parenteral or enteral nutrition.
* Admitted to the ICU in Hospital de Clínicas de Porto Alegre from March 2022 to October 2022.
Exclusion Criteria
* Occurrence of major abdominal surgery during ICU stay
* Tracheostomized patients
* Patients unable to start an oral diet after extubation.
* Patients previously included in the study.
* Patients seeking exclusive palliative care
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Clinicas de Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juliana P Antonio, PhD
Role: PRINCIPAL_INVESTIGATOR
HCPorto Alegre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-0070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.